Claim letter received via email.
Claim letter alleges that the patient has an enlargement in the groin area of unknown origin, elevated chromium and titanium levels, worry and concern.
The claim letter has indicated that the claimant received both the asr xl and the asr resurfacing implants.
This complaint record will capture the asr resurfacing implants.
Doi: (b)(6) 2009.
Dor: scheduled on (b)(6) 2020, (left hip).
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.
This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.
This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.
H10 additional narrative: product complaint (b)(4).
Investigation summary:no device associated with this report was received for examination.
This hip replacement platform was voluntarily recalled from the market and the product codes are now considered inactive.
Depuy considers the investigation closed.
Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|